News
CAMBRIDGE, MA / ACCESS Newswire / July 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on its ...
Merck Foundation Together with African and Asian First Ladies Mark 'World Assisted Reproductive Technology Day' 2025 ...
The Europe trade deal will see the U.S. impose a 15% import tariff on most EU goods − half the threatened rate but much more ...
Merck Foundation has pioneered a new era in fertility care across Africa and Asia by training local embryologists and ...
Although the deal is better than the 30% rate threatened by Trump and will bring clarity for European makers of cars, planes ...
Eckhardt served as head of legal, overseeing M&A, ventures, and finance at the DAX-listed healthcare company based in ...
Merck KGaA, Darmstadt, Germany recently invited leading representatives from the semiconductor industry to Darmstadt to come ...
DARMSTADT, Germany--(BUSINESS WIRE)--Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that it has closed the acquisition of SpringWorks Therapeutics, Inc., for ...
There’s reason to remain bullish about Merck’s growth prospects in the long run. And at a discounted price, the stock could be a steal of a deal.
Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) ...
The simplicity of Merck's monoclonal antibody for RSV in infants could be a plus in its competition with AstraZeneca's existing treatment.
Merck, as it prepares a new version of its cancer blockbuster Keytruda, gets a boost in its patent dispute with Halozyme Therapeutics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results